Indian stock markets opened lower on Wednesday, influenced by mixed global cues and concerns over new US tariffs announced by President Donald Trump. The BSE Sensex fell at the start of the trading ...

Cipla – The company earned 30% of its revenue from North America, ranking among the top 15 U.S. prescription drug providers with a focus on respiratory and oncology generics. Biocon – The U.S. was its ...

India, one of the world's fastest-growing major economies, is projected to experience a slowdown in 2025. Several factors ...

Tata Steel has acquired 191.08 crore equity shares of T Steel Holdings Pte Ltd (TSHP), a company based in Singapore, for $300 million (equivalent to ₹2,603.16 crore).

Equity benchmarks fall for fourth straight session on US tariff concerns, FPI selling, auto and pharma stock drag.

The freeze has put orders and forecasts, particularly those made months in advance, on hold. Read more at straitstimes.com.

The U.S. foreign aid freeze has severely impacted the supply chain for medical products in poor countries, causing potential shortages in HIV and malaria treatments. This disruption affects major ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Indian pharmaceutical companies are expected to maintain their strong presence in the U.S. generic drug market despite ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

U.S. President Donald Trump's proposed tariffs on semiconductors and pharmaceutical imports threaten India's generics industry, a major supplier to the U.S. market. With 31% of their exports sent to ...